Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

Bone metastases represent common long term complications of patients with breast cancer. Zoledronic acid, an amino-bisphosphonate and mevalonate pathway inhibitor, is an established agent for the treatment of bone metastases. Direct antitumor effects of zoledronic acid have been proposed in breast c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Bone Oncol
Autores principales: Wilke, Maria, Göbel, Andy, Rauner, Martina, Benad-Mehner, Peggy, Schütze, Norbert, Füssel, Susanne, Hadji, Peyman, Hofbauer, Lorenz C., Rachner, Tilman D.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2014
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4723419/
https://ncbi.nlm.nih.gov/pubmed/26909293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2014.02.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares